
Internal Reference Number: FOI_8876
Date Request Received: 26/08/2025 00:00:00
Date Request Replied To: 29/09/2025 00:00:00
This response was sent via: By Email
Request Summary: Myeloma
Request Category: Companies
| Question Number 1: Is your health trust currently treating myeloma patients | |
| Answer To Question 1: Yes | |
| Question Number 2: Please list the hospitals in your board/trust that are currently treating myeloma patients. | |
| Answer To Question 2: Salisbury NHS Foundation Trust | |
| Question Number 3: Please list how many myeloma patients are being treated by your board/trust. Please break this down by hospital. | |
| Answer To Question 3: 58 based on patients treated by Salisbury District Hospital from Jan 2024 - August 2025 inclusive. | |
| Question Number 4: Is your health trust currently treating myeloma patients with elranatamab or teclistamab. Please break this down by hospital. | |
| Answer To Question 4: <5 patients | |
| Question Number 5: Please list how many people have been given a) elranatamab or b) teclistamab since approval by the National Institute of Health and Care Excellence in 2024 (TA1023 and TA1015). If possible, please break this down by hospital. | |
| Answer To Question 5: 5 patients on elranatamab, zero teclistamab | |
| Question Number 6: Do you have a service level agreement or referral system in place with any other trusts to deliver a) elranatamab or b) teclistamab to patients. If the answer this question is yes, which health boards / trusts do you have an agreement in place with. | |
| Answer To Question 6: We do not have a formal SLA with any other trusts to deliver these agents. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.